Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

50.05 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,796
Open 50.05
Bid (Size) 49.04 (1,100)
Ask (Size) 49.07 (2,800)
Prev. Close 50.05
Today's Range 50.05 - 50.05
52wk Range 44.62 - 60.12
Shares Outstanding 1,250,690,553
Dividend Yield 4.42%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly... 
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness
Regeneron posts Q3 earnings of $11.83 per share, topping estimates as Dupixent profits lift results despite weaker Eylea sales. 
Via Benzinga

Performance

YTD
+3.9%
+3.9%
1 Month
+0.7%
+0.7%
3 Month
+4.2%
+4.2%
6 Month
-8.3%
-8.3%
1 Year
-5.5%
-5.5%

More News

Read More
Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations
Via MarketMinute
Topics Government World Trade
UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
From Medidata Solutions, Inc.
Via GlobeNewswire
Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark
Via Benzinga
Topics Earnings
Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion
Via Investor's Business Daily
Earnings Scheduled For October 24, 2025
Via Benzinga
Examining the Future: Sanofi's Earnings Outlook
Via Benzinga
Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy
Via Benzinga
Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence
Via MarketMinute
Oil Stocks Rally On Trump's Russia Sanctions: What's Moving Markets Thursday?
Via Benzinga
Topics Government
Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
From Medidata Solutions, Inc.
Via GlobeNewswire
Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease
Via Benzinga
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times
Via Benzinga
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program
Via Stocktwits
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Via Benzinga
Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
Via Investor's Business Daily
Sanofi AlphaMedix Study Hits Key Milestones In Phase 2 Study
Via Benzinga
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September
Via The Motley Fool
AI Revolutionizes Pharma: Market Soars Towards $65 Billion by 2033, Promising a New Era of Medicine
Via TokenRing AI
Topics Artificial Intelligence Economy
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Via MarketMinute
Topics Artificial Intelligence Economy Government
Novavax Amends Deal With Sanofi, Broadens Partnership
Via Stocktwits
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
Via Investor's Business Daily
Immuneering Corporation's Stock Takes a Hit Amidst Funding Round Despite Promising Clinical Data
Via MarketMinute
Amgen Expands US Manufacturing Network Amid New Tariff Policy
Via Benzinga
Topics Government World Trade

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 50.05
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 11/03/25 04:00 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 62.60B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 63B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.